Participant characteristics
A total of 140 patients were randomized to eplerenone or placebo between October 2015 and November 2017. At baseline, an echocardiography was performed on 138 patients (99%), missing two patients from the eplerenone group. Of these patients, an echocardiography was performed on 124 patients after week 26 (89%) (eplerenone As summarized in Table Baseline characteristics according to treatment groupValues are reported as mean (SD) unless otherwise specified. Abbreviations: As previously reported, the fixed titration regimen was well-tolerated. Among patients with an estimated glomerular filtration rate above 60 mL/min/1.73m